The dosage market size value per capita of Penicillins and Streptomycins in Guatemala has shown a fluctuating trend over the last decade. In 2023, the market value stood at $2.36 per capita. Over the past two years, there was a slight increase, with a year-on-year variation of around 2.16% in 2022 and 2.16% in 2023. Analyzing the last five years, the compound annual growth rate (CAGR) was approximately 1.93%, indicating a steady rise in market value per capita.
Future trends to watch for include:
- Potential impacts of healthcare policy changes and increased healthcare access.
- Adoption of advanced medical technologies influencing antibiotic demand.
- Shift in population demographics affecting consumption patterns in Guatemala.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 19 | 19 Peru | 2.49 | 2023 | View data | ||
| 20 | 20 Nicaragua | 2.37 | 2023 | View data | ||
| 21 | 21 Guatemala | 2.36 | 2023 | |||
| 22 | 22 South Africa | 2.34 | 2023 | View data | ||
| 23 | 23 Moldova | 2.19 | 2023 | View data | ||
